Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$208M |
| 2 |
Lowe's Companies
LOW
|
+$198M |
| 3 |
American Tower
AMT
|
+$161M |
| 4 |
Lennar Class A
LEN
|
+$150M |
| 5 |
British American Tobacco
BTI
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$177M |
| 3 |
Crown Castle
CCI
|
+$168M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Entergy
ETR
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.75% |
| 2 | Technology | 13.18% |
| 3 | Healthcare | 11.51% |
| 4 | Industrials | 10.45% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Blackrock
BLK
$183B
| $9.21M | 0.01% |
20,602
+11,576
| +128% | +$4.94M |
|
|
SCMP
1302
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $9.19M | 0.01% |
779,071
-232,406
| -23% | -$2.61M |
|
|
PETQ
1303
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $9.19M | 0.01% |
+339,373
| New | +$8.21M |
|
|
CZZ
1304
DELISTED
Cosan Limited
CZZ
| $9.16M | 0.01% |
1,127,145
-956,447
| -46% | -$7.18M |
|
|
CMCM
1305
Cheetah Mobile
CMCM
$94M
| $9.15M | 0.01% |
217,533
+124,470
| +134% | +$6.35M |
|
1306
Bank of Montreal
BMO
$122B
| $9.14M | 0.01% |
120,750
+97,995
| +431% | +$7.31M |
|
1307
Vipshop
VIPS
$6.78B
| $9.12M | 0.01% |
1,037,243
-1,161,119
| -53% | -$12.1M |
|
1308
AGCO
AGCO
$7.79B
| $9.07M | 0.01% |
122,895
-37,684
| -23% | -$2.64M |
|
1309
Hamilton Lane
HLNE
$4.61B
| $9M | 0.01% |
335,053
-133,331
| -28% | -$3.07M |
|
1310
CBIZ
CBZ
$2.97B
| $8.98M | 0.01% |
552,587
+364,742
| +194% | +$5.5M |
|
1311
Hormel Foods
HRL
$13.1B
| $8.98M | 0.01% |
279,388
-219,719
| -44% | -$7.18M |
|
|
ENV
1312
DELISTED
ENVESTNET, INC.
ENV
| $8.97M | 0.01% |
175,949
-326,896
| -65% | -$14M |
|
1313
AngioDynamics
ANGO
$656M
| $8.97M | 0.01% |
524,861
+176,525
| +51% | +$2.97M |
|
1314
Editas Medicine
EDIT
$496M
| $8.97M | 0.01% |
373,421
+208,773
| +127% | +$3.97M |
|
|
1315
PUT
Blackrock
BLK
$183B
| $8.94M | 0.01% |
+20,000
| New | +$8.54M |
|
|
SEE
1316
DELISTED
Sealed Air
SEE
| $8.88M | 0.01% |
207,840
-213,967
| -51% | -$9.48M |
|
1317
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.6B
| $8.88M | 0.01% |
+100,000
| New | +$8.82M |
|
|
WIN
1318
DELISTED
Windstream Holdings Inc
WIN
| $8.85M | 0.01% |
999,577
-52,894
| -5% | -$701K |
|
1319
ProPetro Holding
PUMP
$1.31B
| $8.84M | 0.01% |
+615,651
| New | +$7.73M |
|
|
GTT
1320
DELISTED
GTT Communications, Inc.
GTT
| $8.83M | 0.01% |
+278,907
| New | +$8.52M |
|
|
MRT
1321
DELISTED
MedEquities Realty Trust, Inc.
MRT
| $8.8M | 0.01% |
749,251
+12,480
| +2% | +$148K |
|
1322
Griffon
GFF
$4.57B
| $8.79M | 0.01% |
395,756
+296,630
| +299% | +$5.96M |
|
1323
Cohu
COHU
$2.39B
| $8.77M | 0.01% |
367,757
+55,103
| +18% | +$1.04M |
|
1324
Group 1 Automotive
GPI
$3.13B
| $8.77M | 0.01% |
120,990
+111,070
| +1,120% | +$6.83M |
|
1325
H&R Block
HRB
$6.56B
| $8.75M | 0.01% |
330,415
-1,110,810
| -77% | -$32.3M |
|
Similar funds
Israel Englander's Q3 2017 Portfolio in Review
As of Q3 2017, Israel Englander held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Israel Englander deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.
- Israel Englander's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
- Israel Englander added most to Salesforce in Q3 2017, an estimated $208M increase.
- Israel Englander's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
- Israel Englander fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
- Israel Englander opened 794 new positions and closed 737 in Q3 2017.
- Israel Englander's portfolio value rose 17% quarter-over-quarter to $65.6B.
Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.